Filing Details
- Accession Number:
- 0001110803-13-000229
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-04 18:59:23
- Reporting Period:
- 2013-05-31
- Filing Date:
- 2013-06-04
- Accepted Time:
- 2013-06-04 18:59:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1562349 | L Mark Lewis | 5200 Illumina Way San Diego CA 92122 | Sr Vp & General Manager | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-31 | 10,000 | $37.04 | 54,552 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-31 | 10,000 | $71.64 | 44,552 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-05-31 | 3,000 | $21.37 | 47,552 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-31 | 3,000 | $72.00 | 44,552 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-05-31 | 3,000 | $0.00 | 3,000 | $21.37 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-05-31 | 10,000 | $0.00 | 10,000 | $37.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-12-15 | 2018-12-15 | No | 4 | M | Direct |
14,500 | 2010-02-27 | 2020-01-27 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 10,000 shares sold ranging from $71.14 to $71.965 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.